Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomic Clinical Decision Support: A Review, How‐to Guide, and Future Vision
Dyson T. Wake, D. Max Smith, Sadaf Kazi, et al.
Clinical Pharmacology & Therapeutics (2021) Vol. 112, Iss. 1, pp. 44-57
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Advancing Pharmacogenomics from Single-Gene to Preemptive Testing
Cyrine E. Haidar, Kristine R. Crews, James M. Hoffman, et al.
Annual Review of Genomics and Human Genetics (2022) Vol. 23, Iss. 1, pp. 449-473
Open Access | Times Cited: 35
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
R COOPERDEHOFF, D. Max Smith, Christina L. Aquilante, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Psychiatric Pharmacogenomic Testing
Lisa Brown, Gwyneth Zai, James L. Kennedy, et al.
Psychiatric Clinics of North America (2025)
Closed Access
Introducing HL7 FHIR Genomics Operations: a developer-friendly approach to genomics-EHR integration
Robert H. Dolin, Bret S.E. Heale, Gil Alterovitz, et al.
Journal of the American Medical Informatics Association (2022) Vol. 30, Iss. 3, pp. 485-493
Open Access | Times Cited: 21
A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial
D. Max Smith, Robel Beyene, Paul Kolm, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Context factors in clinical decision-making: a scoping review
Katharina Schuler, Ian-C. Jung, Maria Zerlik, et al.
BMC Medical Informatics and Decision Making (2025) Vol. 25, Iss. 1
Open Access
Sex and age effects on prevalence of CYP2C19 and CYP2D6 Phenoconversion risk over time in patients with psychosis
Emma Y De Brabander, Nicole Leibold, Thérèse van Amelsvoort, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111363-111363
Closed Access
Pharmacogenomic Clinical Decision Support: A Scoping Review
D. Max Smith, Dyson T. Wake, Henry M. Dunnenberger
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 4, pp. 803-815
Open Access | Times Cited: 16
Integrating pharmacogenomic results in the electronic health record to facilitate precision medicine at a large multisite health system
Sarah Morris, D. Grace Nguyen, Victoria Morris, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2024) Vol. 7, Iss. 8, pp. 845-857
Open Access | Times Cited: 3
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S
Susanne B. Haga
Pharmacy (2023) Vol. 11, Iss. 5, pp. 144-144
Open Access | Times Cited: 8
Early evaluation of a novel alert within cardiac procedural areas to facilitate genotype‐guided antiplatelet therapy
Joel Van Heukelom, Max Weaver, Carson Max, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2024) Vol. 7, Iss. 8, pp. 754-762
Closed Access | Times Cited: 2
How to implement a pharmacogenetics service at your institution
Emily J. Cicali, Lauren Lemke, Hana Al Alshaykh, et al.
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (2022) Vol. 5, Iss. 11, pp. 1161-1175
Open Access | Times Cited: 11
Implementation of pharmacogenomics: Where are we now?
Samantha Medwid, Richard B. Kim
British Journal of Clinical Pharmacology (2022) Vol. 90, Iss. 8, pp. 1763-1781
Open Access | Times Cited: 11
Clinician adherence to pharmacogenomics prescribing recommendations in clinical decision support alerts
Jenny Q. Nguyen, Kristine R. Crews, Ben T Moore, et al.
Journal of the American Medical Informatics Association (2022) Vol. 30, Iss. 1, pp. 132-138
Open Access | Times Cited: 10
Impact of transitioning to an active, noninterruptive CYP2C19/proton pump inhibitor alert on prescribing patterns
Amanda Massmann, Natasha Petry
American Journal of Health-System Pharmacy (2023) Vol. 80, Iss. 15, pp. 1004-1009
Closed Access | Times Cited: 5
Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care
Jasmine H. Hughes, Kara Woo, Ron J. Keizer, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 113, Iss. 3, pp. 565-574
Open Access | Times Cited: 8
Calculation of the pharmacogenomics benefit score for patients with medication-related problems
Thomas M. Polasek
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Public preferences for pharmacogenetic testing in the NHS: Embedding a discrete choice experiment within service design to better meet user needs
John McDermott, Videha Sharma, William G. Newman, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 7, pp. 1699-1710
Open Access | Times Cited: 1
Mapping Medical Context: Workshop-Driven Clustering of Influencing Factors on Medical Decision-Making
Katharina Schuler, Martin Sedlmayr, Brita Sedlmayr
Studies in health technology and informatics (2024)
Open Access | Times Cited: 1
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel
Amanda Massmann, Joel Van Heukelom, Max Weaver, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 8-9, pp. 391-399
Closed Access | Times Cited: 1
Pharmacogenomic alerts: Developing guidance for use by healthcare professionals
John-Paul Carter, James Critchlow, Sarah E. Jackson, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 7, pp. 3201-3210
Open Access | Times Cited: 6
Congruence Rates for Pharmacogenomic Noninterruptive Alerts
Sarah Mills, Amanda Massmann
Pharmacogenomics (2023) Vol. 24, Iss. 9, pp. 493-500
Closed Access | Times Cited: 3
Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
Amanda L. Elchynski, Nina Desai, Danielle D’Silva, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 11, pp. 1227-1227
Open Access | Times Cited: 8
Pharmacogenetics to prevent hypersensitivity reactions to antiepileptic drugs: is testing performed when indicated?
Vy L. Bui, Santiago Álvarez-Arango, James M. Stevenson
Pharmacogenetics and Genomics (2023)
Closed Access | Times Cited: 3
An Expiration Date for Pharmacogenetic Test Results and Prescribing Guidance?
Viviana Hernandez-Martinez, Jorge Ducongé, Gualberto Ruaño
The Journal of Applied Laboratory Medicine (2023) Vol. 8, Iss. 4, pp. 826-830
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top